Authors

1. Abujaradeh , Hiba
2. Mazanec , Susan R.
3. Bender , Catherine M.
4. Connolly , Mary C.
5. Hamilton , Jill B.
6. Brazee , Rachel L.
7. O'Brien , Julia A.
8. Rosenzweig , Margaret

Abstract

Symptom distress during ESBC chemotherapy must be communicated via patient–provider interaction. Patients' perceptions of discrimination and bias may inhibit this process. This interaction requires further interrogation to develop an inclusive symptom communication protocol.